These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
135 related items for PubMed ID: 11031728
1. Enhancement of doxorubicin activity in multidrug-resistant cells by mefloquine. Fujita R, Ishikawa M, Takayanagi M, Takayanagi Y, Sasaki K. Methods Find Exp Clin Pharmacol; 2000 Jun; 22(5):281-4. PubMed ID: 11031728 [Abstract] [Full Text] [Related]
2. Reversal of multidrug resistance in human leukemia K562 by tamolarizine, a novel calcium antagonist. Miyake N, Fujita R, Ishikawa M, Takayanagi M, Takayanagi Y, Sasaki K. Jpn J Pharmacol; 2000 Mar; 82(3):265-8. PubMed ID: 10887958 [Abstract] [Full Text] [Related]
7. Modulation of the function of human MDR1 P-glycoprotein by the antimalarial drug mefloquine. Riffkin CD, Chung R, Wall DM, Zalcberg JR, Cowman AF, Foley M, Tilley L. Biochem Pharmacol; 1996 Nov 22; 52(10):1545-52. PubMed ID: 8937469 [Abstract] [Full Text] [Related]
8. In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576. Mistry P, Stewart AJ, Dangerfield W, Okiji S, Liddle C, Bootle D, Plumb JA, Templeton D, Charlton P. Cancer Res; 2001 Jan 15; 61(2):749-58. PubMed ID: 11212278 [Abstract] [Full Text] [Related]
9. Differential effects of verapamil and quinine on the reversal of doxorubicin resistance in a human leukemia cell line. Bennis S, Ichas F, Robert J. Int J Cancer; 1995 Jul 28; 62(3):283-90. PubMed ID: 7628869 [Abstract] [Full Text] [Related]
10. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by AV200, a new ardeemin derivative. Méndez-Vidal C, Quesada AR. Cancer Lett; 1998 Oct 23; 132(1-2):45-50. PubMed ID: 10397452 [Abstract] [Full Text] [Related]
11. Flow cytometric functional analysis of multidrug resistance by Fluo-3: a comparison with rhodamine-123. Koizumi S, Konishi M, Ichihara T, Wada H, Matsukawa H, Goi K, Mizutani S. Eur J Cancer; 1995 Sep 23; 31A(10):1682-8. PubMed ID: 7488425 [Abstract] [Full Text] [Related]
12. Intrinsic resistance to chemotherapeutic agents in murine osteosarcoma cells. Takeshita H, Kusuzaki K, Ashihara T, Gebhardt MC, Mankin HJ, Hirasawa Y. J Bone Joint Surg Am; 2000 Jul 23; 82-A(7):963-9. PubMed ID: 10901311 [Abstract] [Full Text] [Related]
14. Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells. Stein U, Lage H, Jordan A, Walther W, Bates SE, Litman T, Hohenberger P, Dietel M. Int J Cancer; 2002 Feb 20; 97(6):751-60. PubMed ID: 11857350 [Abstract] [Full Text] [Related]
17. Reversing Multidrug Resistance in Chemo-resistant Human Lung Adenocarcinoma (A549/DOX) Cells by Algerian Propolis Through Direct Inhibiting the P-gp Efflux-pump, G0/G1 Cell Cycle Arrest and Apoptosis Induction. Kebsa W, Lahouel M, Rouibah H, Zihlif M, Ahram M, Abu-Irmaileh B, Mustafa E, Al-Ameer HJ, Al Shhab M. Anticancer Agents Med Chem; 2018 Feb 20; 18(9):1330-1337. PubMed ID: 30088453 [Abstract] [Full Text] [Related]